COVID-19 and Indian pharma industry

Authors : G Vidyasagar

DOI : 10.18231/j.ijpp.2021.017

Volume : 8

Issue : 2

Year : 2021

Page No : 100-101


Citation Data


Related Articles

A review on: Neocov is not new COVID it’s old and similar to SARS

Piyush Kumar Singhal, Gaurav Kumar, Girendra Kumar Gautam, Ravi Kumar, Mohit Kumar, Akansha Nirwal

Glycosylated hemoglobin – A prediction marker for the development of CVD in hypothyroid patients

Naved Ahmad, Mushir Ahmad, Mohd Javed

Breathanalysis of expired carbonmonoxide and its correlation with symptoms of toxicity among urban automobile drivers

Chitra M, Baskara Amsath Raja R, M Semmal

Analysis of synovial biopsies in osteomyelitis in a tertiary care center

Ujjvala Kalluri, Subalakshmi Balasubramanian, Nellaiyappan Balsubramanian

Nanoforensics – Dwarf detectives: A brief review

Mamta Malik, Rakesh Kumar Mishra, Kanwalpreet Kaur, Sanjeev Laller, Vijay Kumar Vijayran

Household poisoning in children: Case series

Shrayash Singh, Sunil, Mukta Rani, Rishabh Kumar Singh

Prevalence of dry eyes in patients with Type-2 diabetes mellitus

Manvi Aggarwal, Rakesh Goud, O K Radhakrishnan, Priyanka Mantri, Arpit Shah

Comparative study of ultrasound assisted versus conventional surface landmark guided technique for combined spinal epidural anaesthesia in patients with increasaed body mass index and difficult surface anatomy of lower back and spinal deformity

Chitrambika P, Madhu Gupta, Mohd Anas Khan

Comparison of sodium fluoride and serum separator tubes for blood glucose estimation – What’s the best option?

Joel Kevin Raj Samuel*, Shanmugapriya Chandrasekaran, Karpaghavalli V. G